Vidac Pharma Holding Company Description

Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells.

It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors.

The company was incorporated in 2021 and is based in London, the United Kingdom.

Vidac Pharma Holding Plc

Country	United Kingdom
Founded	2021
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: 20-22, Wenlock Road London, N1 7GU United Kingdom
Phone	972 54 4257381
Website	vidacpharma.com

Stock Details

Ticker Symbol	T9G
Exchange	Hamburg Stock Exchange
Reporting Currency	EUR
SIC Code	2836